|
1.
|
Byatt N, Simas TA, Lundquist RS, Johnson JV, Ziedonis DM. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynaecol. 2012 Dec; 33(4):143-61.
|
|
|
|
|
2.
|
Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic Association of GABA-A Receptor Alpha-2 and Mu Opioid Receptor with Cocaine Cue-Reactivity: Evidence for Inhibitory Synaptic Neurotransmission Involvement in Cocaine Dependence. Am J Addict. 2012 Sep; 21(5):411-5.
|
|
|
|
|
3.
|
Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101.
|
|
|
|
|
4.
|
Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis DM. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr Clin North Am. 2012 Jun; 35(2):327-56.
|
|
|
|
|
5.
|
Kim SS, Kim SH, Ziedonis D. Tobacco dependence treatment for korean americans: preliminary findings. J Immigr Minor Health. 2012 Jun; 14(3):395-404.
|
|
|
|
|
6.
|
Guydish J, Tajima B, Kulaga A, Zavala R, Brown LS, Bostrom A, Ziedonis D, Chan M. The New York policy on smoking in addiction treatment: findings after 1 year. Am J Public Health. 2012 May; 102(5):e17-25.
|
|
|
|
|
7.
|
Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
|
|
|
|
|
8.
|
Kim SS, Chen W, Kolodziej M, Wang X, Wang VJ, Ziedonis D. A systematic review of smoking cessation intervention studies in china. Nicotine Tob Res. 2011 Aug; 14(8):891-9.
|
|
|
|
|
9.
|
Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, Delucchi K, Zammarelli L, Levy M, Kolodziej M, Brigham G. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012 Feb 1; 121(1-2):30-7.
|
|
|
|
|
10.
|
Wachholtz A, Ziedonis D, Gonzalez G. Comorbid pain and opioid addiction: psychosocial and pharmacological treatments. Subst Use Misuse. 2011; 46(12):1536-52.
|
|
|
|
|
11.
|
Ozhathil DK, Abar B, Baumann BM, Camargo CA, Ziedonis D, Boudreaux ED. The effect of removing cost as a barrier to treatment initiation with outpatient tobacco dependence clinics among emergency department patients. Acad Emerg Med. 2011 Jun; 18(6):662-4.
|
|
|
|
|
12.
|
Boudreaux ED, Moon S, Baumann BM, Camargo CA, O'Hea E, Ziedonis DM. Intentions to quit smoking: causal attribution, perceived illness severity, and event-related fear during an acute health event. Ann Behav Med. 2010 Dec; 40(3):350-5.
|
|
|
|
|
13.
|
Guydish J, Tajima B, Chan M, Delucchi KL, Ziedonis D. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Drug Alcohol Depend. 2011 Apr 1; 114(2-3):237-41.
|
|
|
|
|
14.
|
Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A Brief Treatment Engagement Intervention for Individuals with Co-occurring Mental Illness and Substance Use Disorders: Results of a Randomized Clinical Trial. Community Ment Health J. 2012 Apr; 48(2):127-32.
|
|
|
|
|
15.
|
Chen KW, Comerford A, Shinnick P, Ziedonis DM. Introducing qigong meditation into residential addiction treatment: a pilot study where gender makes a difference. J Altern Complement Med. 2010 Aug; 16(8):875-82.
|
|
|
|
|
16.
|
Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6.
|
|
|
|
|
17.
|
Williams JM, Steinberg ML, Zimmermann MH, Gandhi KK, Stipelman B, Budsock PD, Ziedonis DM. Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. J Subst Abuse Treat. 2010 Jun; 38(4):384-93.
|
|
|
|
|
18.
|
Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010 Feb; 30(1):12-24.
|
|
|
|
|
19.
|
DiFranza J, Ursprung WW, Lauzon B, Bancej C, Wellman RJ, Ziedonis D, Kim SS, Gervais A, Meltzer B, McKay CE, O'Loughlin J, Okoli CT, Fortuna LR, Tremblay M. A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict Behav. 2010 May; 35(5):373-82.
|
|
|
|
|
20.
|
George TP, Ziedonis DM. Addressing tobacco dependence in psychiatric practice: promises and pitfalls. Can J Psychiatry. 2009 Jun; 54(6):353-5.
|
|
|
|
|
21.
|
Boudreaux ED, Baumann BM, Perry J, Marks D, Francies S, Camargo CA, Ziedonis D. Emergency department initiated treatments for tobacco (EDITT): a pilot study. Ann Behav Med. 2008 Dec; 36(3):314-25.
|
|
|
|
|
22.
|
Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008 Dec; 10(12):1691-715.
|
|
|
|
|
23.
|
Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend. 2009 Jan 1; 99(1-3):28-36.
|
|
|
|
|
24.
|
Ross S, Cidambi I, Dermatis H, Weinstein J, Ziedonis D, Roth S, Galanter M. Music therapy: a novel motivational approach for dually diagnosed patients. J Addict Dis. 2008; 27(1):41-53.
|
|
|
|
|
25.
|
Ziedonis DM, Zammarelli L, Seward G, Oliver K, Guydish J, Hobart M, Meltzer B. Addressing tobacco use through organizational change: a case study of an addiction treatment organization. J Psychoactive Drugs. 2007 Dec; 39(4):451-9.
|
|
|
|
|
26.
|
Huang FY, Ziedonis DM, Hu HM, Kline A. Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives. Community Ment Health J. 2008 Feb; 44(1):11-27.
|
|
|
|
|
27.
|
Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug; 9(8):873-81.
|
|
|
|
|
28.
|
Boudreaux ED, Baumann BM, Camargo CA, O'Hea E, Ziedonis DM. Changes in smoking associated with an acute health event: theoretical and practical implications. Ann Behav Med. 2007 Apr; 33(2):189-99.
|
|
|
|
|
29.
|
Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123.
|
|
|
|
|
30.
|
Kim SS, Ziedonis D, Chen KW. Tobacco use and dependence in Asian Americans: a review of the literature. Nicotine Tob Res. 2007 Feb; 9(2):169-84.
|
|
|
|
|
31.
|
Kim SS, Ziedonis D, Chen K. Tobacco use and dependence in Asian American and Pacific Islander adolescents: a review of the literature. J Ethn Subst Abuse. 2007; 6(3-4):113-42.
|
|
|
|
|
32.
|
Steinberg ML, Krejci JA, Collett K, Brandon TH, Ziedonis DM, Chen K. Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addict Behav. 2007 Jul; 32(7):1451-60.
|
|
|
|
|
33.
|
Hu HM, Kline A, Huang FY, Ziedonis DM. Detection of co-occurring mental illness among adult patients in the New Jersey substance abuse treatment system. Am J Public Health. 2006 Oct; 96(10):1785-93.
|
|
|
|
|
34.
|
Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, Zammarelli L, Ziedonis DM, Sears C, McCarty D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2007 Jan; 32(1):53-60.
|
|
|
|
|
35.
|
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82.
|
|
|
|
|
36.
|
Ziedonis D, Haberstroh S, Hanos Zimmermann M, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolesc Med Clin. 2006 Jun; 17(2):381-410.
|
|
|
|
|
37.
|
Williams JM, Ziedonis DM. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behav Healthc. 2006 May; 26(5):27-31.
|
|
|
|
|
38.
|
Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12.
|
|
|
|
|
39.
|
Yanos PT, Ziedonis DM. The patient-oriented clinician-researcher: advantages and challenges of being a double agent. Psychiatr Serv. 2006 Feb; 57(2):249-53.
|
|
|
|
|
40.
|
Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev. 2006 Jan; 25(1):59-71.
|
|
|
|
|
41.
|
Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006; 29(3):228-35.
|
|
|
|
|
42.
|
Foulds J, Williams J, Order-Connors B, Edwards N, Dwyer M, Kline A, Ziedonis DM. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experience. Alcohol Res Health. 2006; 29(3):236-40.
|
|
|
|
|
43.
|
Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7.
|
|
|
|
|
44.
|
Walters ST, Matson SA, Baer JS, Ziedonis DM. Effectiveness of workshop training for psychosocial addiction treatments: a systematic review. J Subst Abuse Treat. 2005 Dec; 29(4):283-93.
|
|
|
|
|
45.
|
Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39.
|
|
|
|
|
46.
|
Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction. 2005 Aug; 100(8):1090-100.
|
|
|
|
|
47.
|
Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005 Nov 15; 79(2-3):323-35.
|
|
|
|
|
48.
|
Williams JM, Foulds J, Dwyer M, Order-Connors B, Springer M, Gadde P, Ziedonis DM. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat. 2005 Jun; 28(4):331-40.
|
|
|
|
|
49.
|
Boudreaux ED, Baumann BM, Friedman K, Ziedonis DM. Smoking stage of change and interest in an emergency department-based intervention. Acad Emerg Med. 2005 Mar; 12(3):211-8.
|
|
|
|
|
50.
|
Steinberg ML, Williams JM, Steinberg HR, Krejci JA, Ziedonis DM. Applicability of the Fagerström Test for Nicotine Dependence in smokers with schizophrenia. Addict Behav. 2005 Jan; 30(1):49-59.
|
|
|
|
|
51.
|
Ziedonis DM. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr. 2004 Dec; 9(12):892-904, 925.
|
|
|
|
|
52.
|
Williams JM, Ziedonis DM, Foulds J. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv. 2004 Sep; 55(9):1064-6.
|
|
|
|
|
53.
|
Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004 Aug; 29(6):1067-83.
|
|
|
|
|
54.
|
Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol. 2004 Aug; 72(4):723-8.
|
|
|
|
|
55.
|
Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
|
|
|
|
|
56.
|
Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control. 2004 Jun; 13(2):206.
|
|
|
|
|
57.
|
Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs. 2004 May; 9(1):39-53.
|
|
|
|
|
58.
|
Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict. 2004; 13 Suppl 1:S42-66.
|
|
|
|
|
59.
|
Krejci J, Steinberg ML, Ziedonis D. Smoking status and substance abuse severity in a residential treatment sample. Drug Alcohol Depend. 2003 Dec 11; 72(3):249-54.
|
|
|
|
|
60.
|
Kampov-Polevoy AB, Ziedonis D, Steinberg ML, Pinsky I, Krejci J, Eick C, Boland G, Khalitov E, Crews FT. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcohol Clin Exp Res. 2003 Dec; 27(12):1929-36.
|
|
|
|
|
61.
|
Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003 Oct; 326(4):223-30.
|
|
|
|
|
62.
|
Williams J, Ziedonis DM. Naltrexone-bupropion combination therapy for protracted abstinence dysphoria. Am J Addict. 2003 May-Jun; 12(3):270-2.
|
|
|
|
|
63.
|
Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J Subst Abuse Treat. 2003 Jan; 24(1):75-9.
|
|
|
|
|
64.
|
Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6.
|
|
|
|
|
65.
|
Roeloffs CA, Wells KB, Ziedonis D, Tang L, Unützer J. Problem substance use among depressed patients in managed primary care. Psychosomatics. 2002 Sep-Oct; 43(5):405-12.
|
|
|
|
|
66.
|
Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
|
|
|
|
|
67.
|
Brewster T, Farentinos C, Ziedonis D. Response: the neurobiological model in community treatment programs. Sci Pract Perspect. 2002 Jul; 1(1):21.
|
|
|
|
|
68.
|
Brewster T, Farentinos C, Ziedonis D. Response: implementing motivational stepped care. Sci Pract Perspect. 2002 Jul; 1(1):47-8.
|
|
|
|
|
69.
|
Smelson DA, Davis CW, Di Pano R, Johnson V, Losonczy MF, Ziedonis D. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis. 2002 Mar; 190(3):200-2.
|
|
|
|
|
70.
|
Krejci J, Ziedonis D. Medications in the treatment of addiction: workplace issues. Occup Med. 2002 Jan-Mar; 17(1):91-104, v.
|
|
|
|
|
71.
|
Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31.
|
|
|
|
|
72.
|
George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000 Nov; 157(11):1835-42.
|
|
|
|
|
73.
|
Woods SW, Ziedonis DM, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of participants and nonparticipants in medication trials for treatment of schizophrenia. Psychiatr Serv. 2000 Jan; 51(1):79-84.
|
|
|
|
|
74.
|
Kraus ML, Ziedonis D, Feinberg MA, Segal SR, Israel L, Kraus MC. A community hospital's ambulatory addiction medicine program. Conn Med. 1998 Feb; 62(2):89-93.
|
|
|
|
|
75.
|
Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20.
|
|
|
|
|
76.
|
Ziedonis D, Brady K. Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness. Med Clin North Am. 1997 Jul; 81(4):1017-36.
|
|
|
|
|
77.
|
Kosten TR, Ziedonis DM. Substance abuse and schizophrenia: editors' introduction. Schizophr Bull. 1997; 23(2):181-6.
|
|
|
|
|
78.
|
Ziedonis DM, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull. 1997; 23(2):229-38.
|
|
|
|
|
79.
|
Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull. 1997; 23(2):247-54.
|
|
|
|
|
80.
|
Farren CK, Clare AW, Ziedonis D, Hammeedi FA, Dinan TG. Evidence for reduced dopamine D2 receptor sensitivity in postwithdrawal alcoholics. Alcohol Clin Exp Res. 1995 Dec; 19(6):1520-4.
|
|
|
|
|
81.
|
Farren CK, Ziedonis D, Clare AW, Hammeedi FA, Dinan TG. D-fenfluramine-induced prolactin responses in postwithdrawal alcoholics and controls. Alcohol Clin Exp Res. 1995 Dec; 19(6):1578-82.
|
|
|
|
|
82.
|
Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):423-8.
|
|
|
|
|
83.
|
George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995 Aug; 56(8):344-6.
|
|
|
|
|
84.
|
Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994 Mar; 45(3):204-6.
|
|
|
|
|
85.
|
Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend. 1994 Mar; 35(1):31-5.
|
|
|
|
|
86.
|
Ziedonis DM, Rayford BS, Bryant KJ, Rounsaville BJ. Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Community Psychiatry. 1994 Jan; 45(1):43-9.
|
|
|
|
|
87.
|
Oliveto A, Kosten T, Schottenfeld R, Ziedonis D. Cocaine abuse among methadone-maintained patients. Am J Psychiatry. 1993 Nov; 150(11):1755.
|
|
|
|
|
88.
|
Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry. 1993 Jul 1-15; 34(1-2):66-74.
|
|
|
|
|
89.
|
Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993 Jun; 181(6):358-64.
|
|
|
|
|
90.
|
Ziedonis D, Richardson T, Lee E, Petrakis I, Kosten T. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharmacol Bull. 1992; 28(3):309-14.
|
|
|
|
|
91.
|
Kosten TR, Rosen MI, Schottenfeld R, Ziedonis D. Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull. 1992; 28(1):15-9.
|
|
|
|
|
92.
|
Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharmacol Bull. 1992; 28(1):21-6.
|
|
|
|
|
93.
|
Ziedonis DM, Kosten TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs. 1991 Oct-Dec; 23(4):417-25.
|
|
|
|
|
94.
|
Ziedonis DM, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull. 1991; 27(3):337-43.
|
|
|
|
|
95.
|
Ziedonis DM, Severs WB, Brennan RW, Page RB. Blood flow and functional responses correlate in the ovine neural lobe. Brain Res. 1986 May 14; 373(1-2):27-34.
|
|
|
|
|
96.
|
Townsend JB, Ziedonis DM, Bryan RM, Brennan RW, Page RB. Choroid plexus blood flow: evidence for dopaminergic influence. Brain Res. 1984 Jan 2; 290(1):165-9.
|
|
|
|
